Attributes | Values |
---|
rdf:type
| |
Description
| - This review summarizes progress in the use of quaternary compounds as acetylcholinesterase (AChE) inhibitors in vitro with respect to their structure and inhibitory ability. Namely, carbamic acid esters, piperidinium and pyridinium salts, bisquaternary pyridinium salts and heterogeneous quaternary inhibitors are all discussed. Among data found in the literature, many compounds have shown promising inhibition of AChE when compared to commercial standards (pyridostigmine, neostigmine). Besides a promising inhibitory ability, selectivity for AChE versus butyrylcholinesterase (BChE) for the most potent compounds (sub-nanomolar IC50) was also identified.
- This review summarizes progress in the use of quaternary compounds as acetylcholinesterase (AChE) inhibitors in vitro with respect to their structure and inhibitory ability. Namely, carbamic acid esters, piperidinium and pyridinium salts, bisquaternary pyridinium salts and heterogeneous quaternary inhibitors are all discussed. Among data found in the literature, many compounds have shown promising inhibition of AChE when compared to commercial standards (pyridostigmine, neostigmine). Besides a promising inhibitory ability, selectivity for AChE versus butyrylcholinesterase (BChE) for the most potent compounds (sub-nanomolar IC50) was also identified. (en)
|
Title
| - Structure-activity relationship of quaternary acetylcholinesterase inhibitors - Outlook for early Myasthenia gravis treatment
- Structure-activity relationship of quaternary acetylcholinesterase inhibitors - Outlook for early Myasthenia gravis treatment (en)
|
skos:prefLabel
| - Structure-activity relationship of quaternary acetylcholinesterase inhibitors - Outlook for early Myasthenia gravis treatment
- Structure-activity relationship of quaternary acetylcholinesterase inhibitors - Outlook for early Myasthenia gravis treatment (en)
|
skos:notation
| - RIV/60162694:G44__/10:00002232!RIV11-GA0-G44_____
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/10:00002232
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - Myasthenia gravis; acetylcholinesterase; inhibitor; quaternary; IC50 (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - AE - Stát Spojené arabské emiráty
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Current Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Doležal, Martin
- Kuča, Kamil
- Musílek, Kamil
- Gunn-Moore, Frank
- Komloova, Markéta
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |